Valion Bio, Inc. (VBIO) Operating income 2021–2025
Valion Bio, Inc. (VBIO) annual operating income history from SEC filings — each fiscal year as reported.
-$7.9MFY2025 · since FY2021: -$5.6M → -$7.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.9M | -76.5% |
| FY2024 | -$4.5M | +45.7% |
| FY2023 | -$8.2M | +18.4% |
| FY2022 | -$10.1M | -79.3% |
| FY2021 | -$5.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VBIO financial trends
VBIO RevenueVBIO Net incomeVBIO Net marginVBIO Gross profitVBIO Gross marginVBIO Operating marginVBIO Operating cash flowVBIO Free cash flowVBIO Capital expendituresVBIO Return on equityVBIO Stock buybacksVBIO Dividends paidVBIO Total assetsVBIO Total liabilitiesVBIO Shareholders’ equityVBIO overview →